Regeneron Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$609.94(as of Jun 18, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regeneron Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$609.94
Ticker SymbolREGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,343
CountyUSA
Market Cap$63,945.5M
EBIDTA4,382.8M
10-Day Moving Average613.58
P/E Ratio14.85
20-Day Moving Average618.36
Forward P/E Ratio13.59
50-Day Moving Average679.41
Earnings per Share40.99
200-Day Moving Average695.44
Profit Margin20.17%
RSI38.04
Shares Outstanding103.0M
ATR17.43
52-Week High818.90
Volume2,609,258
52-Week Low504.84
Book Value31,423.6M
P/B Ratio2.09
Upper Keltner657.58
P/S Ratio4.40
Lower Keltner579.15
Debt-to-Equity Ratio657.58
Next Earnings Date07/30/2026
Cash Surplus-2,145.1M
Next Ex-Dividend DateUnknown
Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.
Regeneron Pharmaceuticals Inc In Our Stock Scanner
As of Jun 18, 2026
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.